Literature DB >> 11323271

The impact of glycobiology on medicine.

J Axford1.   

Abstract

Proteins essential to normal cell physiology are usually glycosylated and variation in their glycosylation patterns often leads to changes in their function. Changes in glycosylation pattern can also be associated with disease. It is now becoming increasingly clear how important it is to understand these changes, to gain insight into their involvement in disease mechanisms and the potential for novel therapeutic interventions.

Mesh:

Substances:

Year:  2001        PMID: 11323271     DOI: 10.1016/s1471-4906(01)01890-7

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  13 in total

1.  Chromophore formation in resorcinarene solutions and the visual detection of mono- and oligosaccharides.

Authors:  Ming He; Rolanda J Johnson; Jorge O Escobedo; Patricia A Beck; Kyu Kwang Kim; Nadia N St Luce; Claude J Davis; Patrick T Lewis; Frank R Fronczek; Bruce J Melancon; Anthony A Mrse; W Dale Treleaven; Robert M Strongin
Journal:  J Am Chem Soc       Date:  2002-05-08       Impact factor: 15.419

Review 2.  Marine glycobiology: current status and future perspectives.

Authors:  Gary S Caldwell; Helen E Pagett
Journal:  Mar Biotechnol (NY)       Date:  2010-06       Impact factor: 3.619

3.  Glycoconjugates prevent B. anthracis toxin-induced cell death through binding while activating macrophages.

Authors:  Olga Tarasenko; Ashley Scott; Lee Soderberg; Pierre Alusta
Journal:  Glycoconj J       Date:  2011-12-02       Impact factor: 2.916

4.  Protein Glycosylation in Diabetes.

Authors:  Tamara Štambuk; Olga Gornik
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 3.650

5.  Polymeric glycoconjugates protect and activate macrophages to promote killing of Bacillus cereus spores during phagocytosis.

Authors:  Olga Tarasenko; Elizabeth Burton; Lee Soderberg; Pierre Alusta
Journal:  Glycoconj J       Date:  2008-01-17       Impact factor: 2.916

6.  Evidence for disruption of sphingolipid metabolism in schizophrenia.

Authors:  Sujatha Narayan; Steven R Head; Timothy J Gilmartin; Brian Dean; Elizabeth A Thomas
Journal:  J Neurosci Res       Date:  2009-01       Impact factor: 4.164

7.  The Q-Trap mass spectrometer, a novel tool in the study of protein glycosylation.

Authors:  K Sandra; B Devreese; J Van Beeumen; I Stals; M Claeyssens
Journal:  J Am Soc Mass Spectrom       Date:  2004-03       Impact factor: 3.109

8.  Killing of Bacillus spores is mediated by nitric oxide and nitric oxide synthase during glycoconjugate-enhanced phagocytosis.

Authors:  Olga Tarasenko; Ashley Scott; Lee Soderberg; Usha Ponnappan; Pierre Alusta
Journal:  Glycoconj J       Date:  2009-06-23       Impact factor: 2.916

9.  GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function.

Authors:  Eke G Gruppen; Ineke J Riphagen; Margery A Connelly; James D Otvos; Stephan J L Bakker; Robin P F Dullaart
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

10.  Analysis of in vitro follicle development during the onset of premature ovarian insufficiency in a mouse model.

Authors:  Heidy Kaune; Sairah Sheikh; Suzannah A Williams
Journal:  Reprod Fertil Dev       Date:  2017-08       Impact factor: 2.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.